Pass the ACDIS Clinical Documentation Specialist CCDS-O Questions and answers with Dumpstech

Compliant querying principles taught in outpatient CDI allow the CDI/coding professional to present a multiple-choice query that includes reasonable diagnostic optionssupported by the current encounter’s clinical indicators. Including a “new” diagnosis as an option is acceptable when it is clinically supported by documented findings (signs/symptoms, test results, treatments, clinical course) and the query is written in a non-leading manner—typically with balanced options and an “other” and/or “unable to determine” choice. This approach helps the provider clarify the most accurate condition being evaluated or treated without steering toward a particular response. Option A is not compliant because relying solely on prior encounter documentation (without current relevance) risks coding historical conditions that are not addressed today. Option B is generally discouraged because calling out HCC status can be perceived as prompting for payment impact rather than clinical accuracy. Option D is incorrect because including relevant clinical indicators is essential; omitting them weakens the clinical basis and does not make a query less leading—rather, it makes it less defensible.

In outpatient CDI, a strong specificity opportunity is to clarify the exactdiagnostic termthat best matches clinical indicators and supports correct ICD-10-CM reporting. The patient has multiple depressive symptoms (weight loss, poor appetite, low energy, impaired concentration), is already treated with an antidepressant (paroxetine), and has aPHQ-9 score of 11, consistent with at least moderate depressive symptom burden that warrants diagnostic clarity. Among the options, onlyMajor Depressive Disorder (MDD)is a recognized clinical diagnosis category with structured ICD-10-CM options that require further specificity (e.g., single vs recurrent episode, severity—mild/moderate/severe, psychotic features, and remission status). The other choices (“occurrence,” “event,” “reaction”) are nonspecific, nonstandard phrases that do not reliably map to accurate ICD-10-CM diagnostic reporting and do not help improve documentation precision. A compliant query would ask the provider to specify whether the patient hasMDDand, if so, document the episode type/severity and relationship to insomnia if clinically relevant, ensuring the record reflects what is being evaluated and treated during the encounter.

In the CMS-HCC model, many related conditions are organized intohierarchiesso that only themost severemanifestation within a disease family contributes to the RAF. This prevents double counting when multiple codes describe progressive severity of the same underlying condition. Cancer categories are a common example: a diagnosis reflectingmetastatic diseaserepresents substantially higher expected resource utilization than a diagnosis of localized/primary malignancy. In this scenario, the February prostate cancer maps to a lower-severity HCC (HCC 23), while the October documentation of prostate cancerwith bone metastasesmaps to a higher-severity HCC (HCC 18). When both are captured within the applicable period, the hierarchy logic retains thehigher-weighted metastatic categoryand suppresses the lower category. The timing of which was coded first does not control the hierarchy outcome, and both HCCs are not counted together when they fall within the same hierarchical grouping. Therefore, the patient’s risk score calculation reflects HCC 18 rather than HCC 23.

A Stage 4 pressure ulcer (pressure injury) is characterized byfull-thickness tissue losswithextensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures. The key phrase in the question—“necrosis of soft tissue through the underlying muscle”—signals a depth of injury that extends beyond the subcutaneous tissue and involves muscle, which is consistent with Stage 4. By comparison, Stage 2 involves partial-thickness skin loss with exposed dermis (no necrosis through deeper structures). Stage 3 involves full-thickness skin loss where adipose may be visible, butmuscle, tendon, or bone are not exposed; undermining and tunneling may occur, yet the defining line is that it does not extend to muscle/bone involvement. “Stage 5” is not part of standard pressure ulcer staging used in coding and documentation. Outpatient CDI practice emphasizes documenting the exact stage, anatomic location, laterality when applicable, and whether the ulcer is healing or complicated (infection/osteomyelitis) because stage drives specificity, severity capture, and appropriate care planning documentation.

In outpatient risk adjustment, the highest-impact clarification is often the one that determines whether a condition is currently active (and therefore risk-adjustable) versus historical/resolved. “Leukemia” listed on the problem list, plus active review of CBC/WBC and referral to oncology, strongly suggests ongoing disease evaluation/management. ACDIS outpatient CDI principles emphasize querying to confirm whether the leukemia is active, in relapse, or in remission because that distinction can change code selection from an active malignancy to a history code, and history codes typically do not carry the same risk adjustment impact as an active HCC-bearing diagnosis. While heart failure type/acuity and malnutrition severity are also important for specificity and may affect risk capture, they generally represent refinement of already-established chronic conditions rather than a potential “on/off” determination of a major disease category. Likewise, atrial fibrillation subtype differentiation is clinically useful but usually does not materially change risk adjustment compared with confirming an active hematologic malignancy. Therefore, clarifying leukemia status/acuity is the most impactful risk-adjusted query opportunity.

In ambulatory CDI, “risk adjustment impact” means the clarification can change whether an HCC-relevant condition is captured accurately (or captured at all) based on ICD-10-CM reporting rules. Here, “DM2 with peripheral neuropathy with diabetic ulcer” already establishes diabeteswith complications, so querying option B adds little—complications are already documented. “Nicotine dependence” is not supported because the patient stopped smoking two years ago; at most, this supports a history of nicotine dependence, which generally does not drive HCC risk scoring. “Morbid obesity” may be clinically relevant (BMI 43 supports it), but obesity typically does not produce meaningful CMS-HCC risk adjustment impact compared with other chronic categories. Thediabetic ulcerdoes matter: correct reporting requires an additional L97.- code that depends onulcer severity/depth(skin breakdown, fat layer exposed, necrosis of muscle/bone). Clarifying depth supports accurate ulcer severity coding and can affect HCC capture/validation for chronic ulcer burden.

CMS-HCC risk adjustment assigns a baseline coefficient (weight) to each qualifying HCC condition, but certaincombinations of conditionscan increase predicted cost beyond what would be expected by simply adding the two individual weights. These added increments are captured throughdisease interaction factors, which apply when specific conditions coexist (for example, diabetes with certain severe complications, or other paired conditions defined by the model). In outpatient CDI, this is why documentation must clearly support both diagnoses—each must be clinically evaluated/managed and meet reporting rules—because accurately capturing the interacting conditions can legitimately increase the beneficiary’s risk score. By contrast,hierarchiesare designed to prevent double-counting within related condition families (the more severe manifestation typically supersedes a less severe one), which often limits—not adds—separate weights.Resource-based relative valuesandconversion factorsbelong to physician fee schedule payment methodology for services/procedures (RVUs and payment conversion), not HCC risk score calculation. Therefore, disease interactions are the correct concept that adds risk score weight beyond individual HCC coefficients.

In outpatient CDI,MEATis a commonly taught framework used to determine whether a condition is sufficiently supported asreportablefor a specific encounter. MEAT stands forMonitor, Evaluate, Assess/Address, and Treat. The concept is that diagnoses should not simply be copied forward on a problem list; they should be tied to provider work and clinical relevance during the visit. “Monitor” includes reviewing status, trends, or test results related to the condition. “Evaluate” includes ordering or interpreting studies, considering disease progression, or documenting response to therapy. “Assess/Address” includes documenting stability, exacerbation, or risk and making a plan (education, counseling, referrals). “Treat” includes medications, procedures, or other therapeutic interventions. Using MEAT helps CDI staff educate providers to document thecurrent statusand management of chronic diseases, supports accurate coding and risk adjustment, and reduces denials by showing medical necessity. OPPS, MACRA, and RADV are important regulatory/payment terms, but they are not the standard acronym used to assess encounter-level reportability.

A leading query is one that steers the provider toward a particular diagnosis or limits clinically appropriate choices in a way that can be perceived as prompting. Option D is leading because it presents a single, high-impact diagnosis (“alcohol dependence”) and forces a binary yes/no response without offering reasonable alternative interpretations (e.g., alcohol use, alcohol abuse/harmful use, dependence in remission, or clinically undetermined) or an “other” option. In addition, it attempts to obtain a potentially new diagnosis based on one data point (quantity consumed) without a balanced set of diagnostic possibilities and supporting clinical indicators (tolerance, withdrawal, impairment, failed attempts to cut down, etc.). By contrast, A is open-ended and requests clarification of the treated condition; B provides two plausible classification choices (active vs history); and C offers multiple reasonable BMI-related diagnostic options plus “other” and “clinically undetermined,” which supports compliant, non-leading clarification. Therefore, D best fits the definition of a leading query.

The documentation explicitly links the conditions by stating “Type 2 Diabetes with bilateral peripheral arteriosclerotic disease of LE,” which supports a diabetic circulatory manifestation rather than “diabetes without complications.” In outpatient CDI chart review, the word “with” and clear provider linkage allow coding of diabetes “with peripheral angiopathy” (a diabetes complication category) when peripheral arterial/arteriosclerotic disease is documented as associated. In addition, best practice is to code both the diabetes complication category and the specific manifestation when supported, because the manifestation (atherosclerosis of the lower extremities, bilateral) further describes the clinical condition being evaluated. Hypertension is also evaluated and managed (“well controlled on Lopressor”), meeting outpatient reporting expectations for an active condition addressed during the encounter. Option D is incorrect because it double-counts the same concept—peripheral angiopathy already represents a circulatory complication, so adding a separate “diabetes with circulatory complication” statement is redundant rather than additive. Therefore, the correct coding set includes diabetes with peripheral angiopathy, the bilateral lower-extremity atherosclerosis manifestation, and hypertension.